211 results
D
BPTH
Bio-Path Holdings Inc
25 Apr 24
$1.28 mm in options / securities to be acquired, sold $1.28 mm, 3 investors
6:04pm
, whether in all instances or due to the nature of the offering that is the subject of this Form D, States cannot
routinely require offering materials
424B5
BPTH
Bio-Path Holdings Inc
19 Apr 24
Prospectus supplement for primary offering
3:28pm
to raise additional capital;
the highly-competitive nature of the pharmaceutical and biotechnology industry and our ability to compete effectively … and commercialization efforts if we are unable to raise additional capital;
the highly-competitive nature of the pharmaceutical and biotechnology industry
8-K
EX-10.1
BPTH
Bio-Path Holdings Inc
19 Apr 24
Bio-Path Holdings, Inc. Announces $1.2 Million Registered Direct Offering Priced At-the- Market Under Nasdaq Rules
9:21am
the nature of the business conducted or property owned by it makes such qualification necessary, except where the failure to be so qualified or in good … and effect as if such payment had not been made or such enforcement or setoff had not occurred.
5.17 Independent Nature of Purchasers’ Obligations
424B5
BPTH
Bio-Path Holdings Inc
19 Apr 24
Prospectus supplement for primary offering
9:17am
are unable to raise additional capital;
the highly-competitive nature of the pharmaceutical and biotechnology industry and our ability to compete … if we are unable to raise additional capital;
the highly-competitive nature of the pharmaceutical and biotechnology industry and our ability to compete
D
htq428zcysh
5 Apr 24
$317.93 k in options / securities to be acquired, sold $317.93 k, 1 investor
4:01pm
8-K
EX-10.1
gfohw6cg64e91a4demu2
4 Apr 24
Entry into a Material Definitive Agreement
4:35pm
424B5
abiap
4 Apr 24
Prospectus supplement for primary offering
4:33pm
424B5
nyx0sn q4m6
27 Mar 24
Prospectus supplement for primary offering
8:15am
8-K
EX-10.1
nrcn3rb a27kd641
26 Mar 24
Entry into a Material Definitive Agreement
8:03am